# CME Group Inc. (CME) Q2 2025 Financial Results Summary
CME Group Inc. (NASDAQ: CME) released its financial results for the second quarter of 2025 on July 23, 2025. The results demonstrated significant growth across various metrics, highlighting the company’s strong performance in a competitive marketplace.
### Key Financial Metrics
– **Revenue**: $1.7 billion
– Up **10%** compared to Q2 2024
– **Operating Income**: $1.1 billion
– **Net Income**: $1.0 billion
– **Diluted Earnings per Share (EPS)**: $2.81
– Up **15.6%** compared to Q2 2024 (EPS was $2.43)
– **Adjusted Net Income**: $1.1 billion
– **Adjusted Diluted EPS**: $2.96
– Up **15.6%** compared to Q2 2024 (Adjusted EPS was $2.56)
### Trading Performance
– **Average Daily Volume (ADV)**:
– Reached **30.2 million contracts**
– Up **16%** from Q2 2024, which had an ADV of **25.9 million contracts**
– **New Retail Traders**: Increased by **57%** year over year
– **Micros ADV**: Increased to **4.1 million contracts**
### Revenue Breakdown
– **Clearing and Transaction Fees Revenue**: $1.4 billion
– Market Data Revenue: $198 million
– Total Average Rate per Contract: $0.690
### Cash Position and Shareholder Returns
– **Cash**: $2.2 billion (includes $200 million with Fixed Income Clearing Corporation)
– **Debt**: $3.4 billion
– **Dividends Paid**: Approximately **$3.0 billion** in the first six months of 2025
– **Total Shareholder Returns**: $29.1 billion since variable dividend policy inception in early 2012
### Financial Highlights
– Comparing **Q2 2025** vs. **Q2 2024**:
– **Total Revenues**: Up **10.4%** ($1.692 billion vs. $1.533 billion)
– **Total Expenses**: Increased slightly to $562.7 million (up **5.8%** from $531.9 million)
– **Operating Income**: Up **12.9%** ($1.129 billion vs. $1.001 billion)
– **Net Income**: Up **16.1%** ($1.025 billion vs. $883.2 million)
### Earnings and Shares
– **Basic and Diluted EPS** were both $2.81 up from **$2.43** in Q2 2024.
– **Weighted Average Number of Common Shares**:
– Basic: 359.7 million
– Diluted: 360.4 million
### Conference Call
CME Group will host a Q&A conference call at 8:30 a.m. Eastern Time to discuss these financial results in detail, which will be available via a live audio webcast on the CME Group’s Investor Relations page.
### Conclusion
CME Group’s financial results for Q2 2025 reflect strong year-over-year growth across all major metrics. The robust increase in both revenue and net income indicates successful demand for their products, with the company achieving new highs in operational performance. Additionally, the commitment to returning capital to shareholders through substantial dividends demonstrates their ongoing strategy of delivering value to investors.
Here are the extracted tables from the press release:
### Consolidated Balance Sheets (in millions)
| ASSETS | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Current Assets: | ||
| Cash and cash equivalents | 1,981.3 | 2,892.4 |
| Marketable securities | 117.6 | 113.2 |
| Accounts receivable, net of allowance | 667.6 | 573.1 |
| Other current assets (includes $6.5 and $6.3 in restricted cash) | 525.6 | 559.4 |
| Performance bonds and guaranty fund contributions | 142,158.0 | 98,895.4 |
| Total current assets | 145,450.1 | 103,033.5 |
| Property, net of accumulated depreciation and amortization | 362.9 | 386.2 |
| Intangible assets—trading products | 17,175.3 | 17,175.3 |
| Intangible assets—other, net | 2,728.5 | 2,821.6 |
| Goodwill | 10,523.9 | 10,486.9 |
| Other assets | 3,666.3 | 3,543.5 |
| Total Assets | 179,907.0 | 137,447.0 |
| LIABILITIES AND EQUITY | ||
| Current Liabilities: | ||
| Accounts payable | 92.3 | 79.9 |
| Short-term debt | — | 749.8 |
| Other current liabilities | 544.5 | 2,588.8 |
| Performance bonds and guaranty fund contributions | 142,158.0 | 98,895.4 |
| Total current liabilities | 142,794.8 | 102,313.9 |
| Long-term debt | 3,420.4 | 2,678.2 |
| Deferred income tax liabilities, net | 5,232.6 | 5,246.8 |
| Other liabilities | 720.2 | 721.2 |
| Total Liabilities | 152,168.0 | 110,960.1 |
| Total CME Group Shareholders’ Equity | 27,739.0 | 26,486.9 |
| Total Liabilities and Equity | 179,907.0 | 137,447.0 |
### Consolidated Statements of Income (dollars in millions, except per share amounts; shares in thousands)
| Revenues | Quarter Ended | Six Months Ended | ||
|---|---|---|---|---|
| June 30, 2025 | 2024 | June 30, 2025 | 2024 | |
| Clearing and transaction fees | 1,388.0 | 1,249.9 | 2,725.3 | 2,458.8 |
| Market data and information services | 198.1 | 175.0 | 392.6 | 350.4 |
| Other | 105.9 | 107.6 | 216.4 | 211.2 |
| Total Revenues | 1,692.0 | 1,532.5 | 3,334.3 | 3,020.4 |
| Expenses | ||||
| Compensation and benefits | 221.6 | 204.7 | 428.3 | 410.7 |
| Technology | 70.9 | 64.1 | 136.6 | 123.5 |
| Professional fees and outside services | 37.4 | 34.7 | 65.9 | 67.8 |
| Amortization of purchased intangibles | 56.1 | 55.5 | 111.3 | 110.7 |
| Depreciation and amortization | 27.3 | 28.7 | 54.6 | 58.8 |
| Licensing and other fee agreements | 96.2 | 85.9 | 192.8 | 173.8 |
| Other | 53.2 | 58.3 | 107.5 | 114.9 |
| Total Expenses | 562.7 | 531.9 | 1,097.0 | 1,060.2 |
| Operating Income | 1,129.3 | 1,000.6 | 2,237.3 | 1,960.2 |
| Non-Operating Income (Expense) | ||||
| Investment income | 1,518.4 | 1,044.5 | 2,411.1 | 2,115.8 |
| Interest and other borrowing costs | -44.0 | -40.1 | -85.7 | -80.0 |
| Equity in net earnings of unconsolidated subsidiaries | 99.0 | 86.4 | 187.2 | 173.6 |
| Other non-operating income (expense) | -1,372.4 | -936.9 | -2,174.8 | -1,901.7 |
| Total Non-Operating Income (Expense) | 201.0 | 153.9 | 337.8 | 307.7 |
| Income before Income Taxes | 1,330.3 | 1,154.5 | 2,575.1 | 2,267.9 |
| Income tax provision | 305.2 | 271.3 | 593.8 | 529.5 |
| Net Income | 1,025.1 | 883.2 | 1,981.3 | 1,738.4 |
| Net Income Attributable to Common Shareholders of CME Group | 1,012.2 | 872.1 | 1,956.4 | 1,716.5 |
| Earnings per Share Attributable to Common Shareholders of CME Group: | ||||
| Basic | 2.81 | 2.43 | 5.44 | 4.78 |
| Diluted | 2.81 | 2.42 | 5.43 | 4.77 |
| Weighted Average Number of Common Shares: | ||||
| Basic | 359,658 | 359,330 | 359,636 | 359,294 |
| Diluted | 360,355 | 359,869 | 360,297 | 359,852 |
